Hemodynamics, fluids & transfusion

Viscoelastic versus conventional coagulation tests to reduce blood product transfusion in patients undergoing liver transplantation: A systematic review and meta-analysis

Eur J AnaesthesiolPublished Systematic review and meta-analysis of randomised and nonrandomised clinical trials

Authors' conclusion

Our meta-analysis demonstrated that VETs implementation was associated with reduced RBC and FFP consumption in liver transplantation patients without effects on mortality and hospital and ICU-LOS.

Study context

Population
Liver transplantation recipients, operating room17 studies (15 observational, 2 RCTs)
Participants
5,345 recipients
Comparison
Viscoelastic test (VET)-guided vs CCT-guided coagulation management
Outcome
Mean number of transfused units for each blood product (RBC, fresh frozen plasma (FFP), platelets, cryoprecipitate)
Methodological detailsPRISMA guidelines, previously published protocol, Databases searched up to 30 January 2022
  • PRISMA guidelines
  • Previously published protocol
  • Databases searched up to 30 January 2022

Pooled result

As reported in the abstract

Transfused units per blood product
VETs vs CCTsMean difference, RBC units (95% CI)P value
I2 = 61%
−1.40(−1.87 to −0.92)
P < 0.001
VETs vs CCTsMean difference, FFP units (95% CI)P value
I2 = 98%
−2.98(−4.61 to −1.35)
P = < 0.001
VETs vs CCTsMean difference, cryoprecipitate (95% CI)P value
I2 = 91%
2.71(0.84–4.58)
P = 0.005

Further pooled results

Mortality, hospital length of stay (LOS) and intensive care unit (ICU) LOS

No significant difference

Original publication

Viscoelastic versus conventional coagulation tests to reduce blood product transfusion in patients undergoing liver transplantation: A systematic review and meta-analysis. Eur J Anaesthesiol. Published 22 November 2022. doi:10.1097/eja.0000000000001780

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.